Investor Home
 | 2011 Annual Report |
| Stock Quote |
 |
| Corporate Profile |
|
| Recent News | More >> |
| MediciNova Reports First Quarter 2012 Results - 05/10/12 |
| SAN DIEGO, May 10, 2012 (GLOBE NEWSWIRE) -- MediciNova, Inc. a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange (Code Number: 4875), announced financial results for the ... More >> |
|
| MediciNova Receives Notice of an Australian Patent Allowance for a Method of Treating Neuropathic Pain - 04/23/12 |
| SAN DIEGO, Apr 23, 2012 (GlobeNewswire via COMTEX) --MediciNova Inc, a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange (Code Number: 4875), today announced that it has ... More >> |
|
| MediciNova Appoints David O'Toole CPA to its Board of Directors - 04/10/12 |
| SAN DIEGO, April 10, 2012 (GLOBE NEWSWIRE) -- MediciNova, Inc. a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange (Code Number:4875), today announced the appointment of ... More >> |
|
| MediciNova Reports Fourth Quarter and Full Year 2011 Results - 03/29/12 |
| SAN DIEGO, March 29, 2012 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV - News) and the Jasdaq Market of the Osaka Securities Exchange (Code Number: 4875), today announced financial ... More >> |
|
| MediciNova Management to Host a Conference Call to Discuss 2011 Earnings Thursday, March 29th at 5:00 P.M. (EDT) - 03/22/12 |
| SAN DIEGO, March 22, 2012 (GLOBE NEWSWIRE) -- MediciNova, Inc. a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange (Code Number: 4875), today announced it will report fou... More >> |
|
| MediciNova Completes Enrollment in Phase 2 MN-221 Trial Treating Patients Suffering from Acute Exacerbations of Asthma - 03/21/12 |
| SAN DIEGO, March 21, 2012 (GLOBE NEWSWIRE) -- MediciNova, Inc. a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange (4875), today announced it has completed enrollment in ... More >> |
|
| MediciNova Receives Notice of a Japanese Patent Allowance for a Method of Treating Neuropathic Pain - 03/13/12 |
| Claims Cover the Use of Ibudilast for Certain Neuropathic Pain Conditions SAN DIEGO, March 13, 2012 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka... More >> |
|
| MediciNova to Present at American Academy of Emergency Medicine Annual Meeting - 02/08/12 |
| SAN DIEGO, Feb. 8, 2012 (GLOBE NEWSWIRE) -- MediciNova Inc, a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange (4875), will be presenting at the 18th annual American Aca... More >> |
|
| MediciNova Receives a Notice of Patent Allowance for a Method of Treating Progressive Multiple Sclerosis - 02/01/12 |
| Claims Cover the Use of Ibudilast for Primary or Secondary Progressive Multiple Sclerosis SAN DIEGO, Calif., Feb. 1, 2012 (GLOBE NEWSWIRE) -- MediciNova Inc, a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Jasdaq... More >> |
|
| MediciNova and University of Colorado Boulder Collaborate on Potential Novel Therapy for Traumatic Brain Injury - 01/16/12 |
| SAN DIEGO, Jan 16, 2012 (GlobeNewswire via COMTEX) --MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange (4875), and the University of ... More >> |
|
|
| Upcoming Events | More >> |
| There are currently no events scheduled. |
|
| What's New |
| There are currently no items available. |
|
Receive E-mail Alerts |
| Sign up to receive e-mail alerts whenever Medicinova Inc posts new information to the site. Just enter your e-mail address and click Submit. |
|
 Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. |
Investor Tools
 | Print Page |
 | E-mail Page |
 | RSS Feeds |
 | E-mail Alerts |
 | IR Contacts |
Stock Information
|
MNOV (Common)
$3.23 + 0.17 | 05/17/12 4:00 p.m. ET |
|
